Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
China Pharmaceutical Chain Industry Report, 2009
Management Report
Published: October 2009
Pages: 68
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 1000.00 Buy Now!
Research from: ResearchInChina
Sector: Prescription Medicines
According to the chain drug stores ranking in China in 2009, top 100 enterprises in China pharmaceutical chain industry achieved the sales revenue of RMB57.24 billion in 2008, increasing by RMB13.33 billion (30.35%) than RMB43.91 billion in 2007.
In 2008, the average profit margin of top 100 enterprises was 3.76%, more 0.76 points than that in 2007
The data of this report come from China Association of Pharmaceutical Commerce, www.pharmnet.com.cn, www.ydzz.com and the National Bureau of Statistics of China. The report makes an in-depth analysis of the operation and future development of pharmaceutical chain industry, guiding investment and financing decision-making.
This report includes 8 chapters and 65 diagrams, covering all major aspects and key enterprises in China pharmaceutical chain industry. Chapter 1 introduces the development of China pharmaceutical chain industry briefly. Chapter 2 analyzes the macroeconomic environment, industry environment and policies related with China pharmaceutical chain industry. Chapter 3, 4, 5 analyze operation, competition patterns and key areas of China pharmaceutical chain industry, such as market scale, profitability, competition patterns and regional difference. Chapter 6 analyzes the development trends of China pharmaceutical chain industry. Finally, Chapter 7 analyzes the development, revenue distribution and profitability of over 10 key Chinese pharmaceutical enterprises, including LBX Pharmacy, Nepstar, Hubei Tongjitang, Chongqing Tongjunge Pharmacy, Sinopharm Group Co., Ltd., Chongqing Peace Drugstore.
In 2008, the average profit margin of top 100 enterprises was 3.76%, more 0.76 points than that in 2007
The data of this report come from China Association of Pharmaceutical Commerce, www.pharmnet.com.cn, www.ydzz.com and the National Bureau of Statistics of China. The report makes an in-depth analysis of the operation and future development of pharmaceutical chain industry, guiding investment and financing decision-making.
This report includes 8 chapters and 65 diagrams, covering all major aspects and key enterprises in China pharmaceutical chain industry. Chapter 1 introduces the development of China pharmaceutical chain industry briefly. Chapter 2 analyzes the macroeconomic environment, industry environment and policies related with China pharmaceutical chain industry. Chapter 3, 4, 5 analyze operation, competition patterns and key areas of China pharmaceutical chain industry, such as market scale, profitability, competition patterns and regional difference. Chapter 6 analyzes the development trends of China pharmaceutical chain industry. Finally, Chapter 7 analyzes the development, revenue distribution and profitability of over 10 key Chinese pharmaceutical enterprises, including LBX Pharmacy, Nepstar, Hubei Tongjitang, Chongqing Tongjunge Pharmacy, Sinopharm Group Co., Ltd., Chongqing Peace Drugstore.